We presented our pioneering DCT with RedHill Biopharma in front of 500+ senior executives from big pharma – offering a roadmap to at-home monitoring of infectious disease. By pairing FDA-approved devices with our patient-friendly virtual study platform and app, we’ve enabled remote monitoring of patient vitals formerly confined to the lab or clinic. Since most COVID-19 patients are recovering from illness at home, we’ve brought the research setting to them. Our presentation highlights the study design of this groundbreaking remote clinical trial.